The epidermal growth factor (EGF) regulator pathway is a known contributor to hepatic fibrosis and cirrhosis, and serum EGF upregulation seemed to be associated with liver regeneration, reparation, and improved KPE outcomes in an analysis of 67 postoperative BA patients stratified for their outcome [38]. Here, EGF is linked to breast angiosarcoma.